Dynamic remodeling of the KRAS interactome by direct RAS inhibitors with distinct mechanism of action reveals convergent responses
Open Access
- 16 October 2026
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 45 (46) , 4990-5001
Abstract
KRAS is mutated in 30% of all human cancers. Small molecule inhibitors targeting KRAS with distinct mechanisms-of-action and variable specificities have entered the clinic, but their full effect on the RAS signaling network remains unclear. Here, we described the impact of RAS inhibition on the KRAS interactome using Proximity-dependent Biotin Identification. Two inhibitors were used: panRAS-ON, which forms a ternary complex between cyclophilin and RAS in the GTP-bound state; panKRAS-off, which binds to the KRAS switch II pocket. RAS inhibitors were found to significantly alter 16.5% of proteins in proximity to KRAS. Despite their distinct modality, the KRAS inhibitors induced highly correlated changes in the KRAS interactomes. Among KRAS-proximal proteins, Afadin was highly affected by RAS inhibition. AFDN is a key regulator of cell motility, invasion, and metastasis. Analysis of AFDN phosphorylation revealed that AKT only partially modulates p-Ser1718, while KRAS inhibition sufficiently abolished EGF-mediated AFDN phosphorylation. Silencing AFDN in a KRAS-driven non-small cell lung cancer model abolished chemotaxis and disrupted directional migration in an EGF-driven wound healing model. We demonstrated that KRAS is a central node in regulating growth factor-induced cell migration, and that KRAS inhibition plays a broader role than MAPK-mediated cell proliferation and survival.Keywords
This publication has 44 references indexed in Scilit:
- Switch II Pocket Inhibitor Allosterically Freezes KRASG12D Nucleotide-binding Site and Arrests the GTPase CycleJournal of Molecular Biology, 2025
- The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4ACell Reports, 2024
- Defining bone fide effectors of RAS GTPasesBioEssays, 2023
- Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory rolesBioEssays, 2020
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2Molecular Cell, 2019
- Differential Effector Engagement by Oncogenic KRASCell Reports, 2018
- Untangling cell tracks: Quantifying cell migration by time lapse image data analysisCytometry Part A, 2017
- Meet the neighbors: Mapping local protein interactomes by proximity‐dependent labeling with BioIDProteomics, 2016
- Oncogenic Ras and its role in tumor cell invasion and metastasisSeminars in Cancer Biology, 2004